[HTML][HTML] Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration

SK Jha, NK Jha, D Kumar, RK Ambasta… - Biochimica et Biophysica …, 2017 - Elsevier
Mounting evidence suggests a link between metabolic syndrome (MetS) such as diabetes,
obesity, non-alcoholic fatty liver disease in the progression of Alzheimer's disease (AD) …

Neurotoxic agent-induced injury in neurodegenerative disease model: Focus on involvement of glutamate receptors

M Jakaria, SY Park, ME Haque… - Frontiers in molecular …, 2018 - frontiersin.org
Glutamate receptors play a crucial role in the central nervous system and are implicated in
different brain disorders. They play a significant role in the pathogenesis of …

Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania

M Gardea-Resendez, BJ Coombes, M Veldic… - Molecular …, 2023 - nature.com
Preclinical evidence suggests that antidepressants (ADs) may differentially influence
mitochondrial energetics. This study was conducted to investigate the relationship between …

Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory …

PT Lum, M Sekar, LJ Seow, MF Shaikh… - Frontiers in …, 2023 - frontiersin.org
Huntington's disease (HD), a neurodegenerative disease, normally starts in the prime of
adult life, followed by a gradual occurrence of psychiatric disturbances, cognitive and motor …

An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a huntington's disease model and its relevance to drug …

S Upadhayay, NG Yedke, V Rahi, S Singh… - Neurochemical …, 2023 - Springer
Animal models are used to better understand the various mechanisms involved in the
pathogenesis of diseases and explore potential pathways that will aid in discovering …

Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders

S Mehan, S Parveen, S Kalra - Neural regeneration research, 2017 - journals.lww.com
Long term suppression of succinate dehydrogenase by selective inhibitor 3-nitropropionic
acid has been used in rodents to model Huntington's disease where mitochondrial …

Effect of neuropsychiatric medications on mitochondrial function: For better or for worse

TL Emmerzaal, G Nijkamp, M Veldic, S Rahman… - … & biobehavioral reviews, 2021 - Elsevier
Individuals with mitochondrial disease often present with psychopathological comorbidity,
and mitochondrial dysfunction has been proposed as the underlying pathobiology in various …

Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research

DJ van Rensburg, Z Lindeque, BH Harvey, SF Steyn - Mitochondrion, 2022 - Elsevier
Neuropsychiatric disorders have complex pathophysiological constructs, requiring
translational models to improve our understanding thereof. Mitochondrial dysfunction …

Brain cytochrome‐c‐oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS

L Holper, MJ Lan, PJ Brown, EM Sublette… - Depression and …, 2019 - Wiley Online Library
Background Brain mitochondrial dysfunction is implicated in the pathophysiology of mood
disorders. Brain cytochrome‐c‐oxidase (COX) activity is associated with the mitochondrial …

Peripheral non-enzymatic antioxidants as biomarkers for mood disorders: Evidence from a machine learning prediction model

Y Gong, Z Lu, Z Kang, X Feng, Y Zhang, Y Sun… - Frontiers in …, 2022 - frontiersin.org
Background Oxidative stress is related to the pathogenesis of mood disorders, and the level
of oxidative stress may differ between bipolar disorder (BD) and major depressive disorder …